Liberty Wealth Management’s Nektar Therapeutics NKTR Stock Holding History

Liberty Wealth Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,267	Closed	-$12.9K	–	234
2025 Q1	$12.9K	Hold	1,267	–	–	﹤0.01%	154
2024 Q4	$17.7K	Hold	1,267	–	–	﹤0.01%	225
2024 Q3	$25K	Hold	1,267	–	–	﹤0.01%	224
2024 Q2	$24K	Hold	1,267	–	–	﹤0.01%	223
2024 Q1	$18K	Hold	1,267	–	–	﹤0.01%	185
2023 Q4	$11K	Hold	1,267	–	–	﹤0.01%	169
2023 Q3	$11K	Hold	1,267	–	–	﹤0.01%	174
2023 Q2	$10.9K	Hold	1,267	–	–	﹤0.01%	191
2023 Q1	$13.4K	Buy	+1,267	New	+$38.3K	﹤0.01%	229
2022 Q3	$61K	Hold	1,275	–	–	0.02%	149
2022 Q2	$72K	Hold	1,275	–	–	0.03%	149
2022 Q1	$103K	Hold	1,275	–	–	0.04%	158
2021 Q4	$258	Hold	1,275	–	–	0.01%	132
2021 Q3	$343K	Hold	1,275	–	–	0.12%	106
2021 Q2	$328K	Buy	1,275 +8	+0.6%	+$2.21K	0.13%	90
2021 Q1	$393K	Hold	1,267	–	–	0.19%	74
2020 Q4	$393K	Buy	1,267 +334	+36%	+$86.3K	0.19%	74
2020 Q3	$232K	Hold	933	–	–	0.14%	82
2020 Q2	$324K	Hold	933	–	–	0.23%	67
2020 Q1	$250K	Buy	+933	New	+$289K	0.22%	70
2019 Q4	–	Sell	-191	Closed	-$55.4K	–	945
2019 Q3	$52K	Buy	191 +178	+1,369%	+$65.3K	0.05%	224
2019 Q2	$7K	Buy	+13	New	+$6.52K	0.01%	597

Other funds holding NKTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Liberty Wealth Management's NKTR Position: Q2 2025 in Review

Liberty Wealth Management sold out of Nektar Therapeutics (NKTR) in Q2 2025, closing a stake of 1,267 shares — an estimated $12.9K sold.

Liberty Wealth Management first reported a position in NKTR in Q2 2019 and held it in 22 quarters. The position peaked at $393K in Q1 2021. 109 funds tracked by Wall St. Rank hold NKTR as of Q2 2025.

Liberty Wealth Management reported no remaining Nektar Therapeutics position as of Q2 2025 after selling out during the quarter.
Liberty Wealth Management sold 1,267 Nektar Therapeutics shares in Q2 2025, an estimated $12.9K.
Liberty Wealth Management first reported a position in Nektar Therapeutics in Q2 2019 and held it in 22 quarters.
Liberty Wealth Management's Nektar Therapeutics position peaked at $393K in Q1 2021.
109 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2025.

Based on Liberty Wealth Management's 13F filing for Q2 2025, filed 1 Aug 2025.